184 related articles for article (PubMed ID: 30484063)
1. Primary Tumor Resection for Stage IV Colorectal Cancer in the Era of Targeted Chemotherapy.
Shida D; Boku N; Tanabe T; Yoshida T; Tsukamoto S; Takashima A; Kanemitsu Y
J Gastrointest Surg; 2019 Nov; 23(11):2144-2150. PubMed ID: 30484063
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Impact of Palliative Primary Tumor Resection for Unresectable Stage 4 Colorectal Cancer: Using a Propensity Score Analysis.
Shida D; Hamaguchi T; Ochiai H; Tsukamoto S; Takashima A; Boku N; Kanemitsu Y
Ann Surg Oncol; 2016 Oct; 23(11):3602-3608. PubMed ID: 27272107
[TBL] [Abstract][Full Text] [Related]
3. Primary Tumor-Related Complications Among Patients With Unresectable Stage IV Colorectal Cancer in the Era of Targeted Therapy: A Competing Risk Regression Analysis.
Tanabe T; Shida D; Boku N; Yoshida T; Tsukamoto S; Takashima A; Kanemitsu Y
Dis Colon Rectum; 2021 Sep; 64(9):1074-1082. PubMed ID: 34397558
[TBL] [Abstract][Full Text] [Related]
4. The role of palliative resection for asymptomatic primary tumor in patients with unresectable stage IV colorectal cancer.
Yun JA; Huh JW; Park YA; Cho YB; Yun SH; Kim HC; Lee WY; Chun HK
Dis Colon Rectum; 2014 Sep; 57(9):1049-58. PubMed ID: 25101600
[TBL] [Abstract][Full Text] [Related]
5. Surgical Resection of the Primary Tumor in Stage IV Colorectal Cancer Without Metastasectomy is Associated With Improved Overall Survival Compared With Chemotherapy/Radiation Therapy Alone.
Gulack BC; Nussbaum DP; Keenan JE; Ganapathi AM; Sun Z; Worni M; Migaly J; Mantyh CR
Dis Colon Rectum; 2016 Apr; 59(4):299-305. PubMed ID: 26953988
[TBL] [Abstract][Full Text] [Related]
6. Benefit of Surgical Resection of the Primary Tumor in Patients Undergoing Chemotherapy for Stage IV Colorectal Cancer with Unresected Metastasis.
Maroney S; de Paz CC; Reeves ME; Garberoglio C; Raskin E; Senthil M; Namm JP; Solomon N
J Gastrointest Surg; 2018 Mar; 22(3):460-466. PubMed ID: 29124549
[TBL] [Abstract][Full Text] [Related]
7. Palliative resection of the primary tumor is associated with improved overall survival in incurable stage IV colorectal cancer: A nationwide population-based propensity-score adjusted study in the Netherlands.
't Lam-Boer J; Van der Geest LG; Verhoef C; Elferink ME; Koopman M; de Wilt JH
Int J Cancer; 2016 Nov; 139(9):2082-94. PubMed ID: 27342618
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Impact of R0 Resection and Targeted Therapy for Colorectal Cancer with Synchronous Peritoneal Metastasis.
Shida D; Yoshida T; Tanabe T; Tsukamoto S; Ochiai H; Kanemitsu Y
Ann Surg Oncol; 2018 Jun; 25(6):1646-1653. PubMed ID: 29572704
[TBL] [Abstract][Full Text] [Related]
9. Impact of Primary Tumor Location on First-line Bevacizumab or Cetuximab in Metastatic Colorectal Cancer.
Snyder M; Bottiglieri S; Almhanna K
Rev Recent Clin Trials; 2018; 13(2):139-149. PubMed ID: 29595113
[TBL] [Abstract][Full Text] [Related]
10. Final results and outcomes by prior bevacizumab exposure, skin toxicity, and hypomagnesaemia from ASPECCT: randomized phase 3 non-inferiority study of panitumumab versus cetuximab in chemorefractory wild-type KRAS exon 2 metastatic colorectal cancer.
Price T; Kim TW; Li J; Cascinu S; Ruff P; Suresh AS; Thomas A; Tjulandin S; Guan X; Peeters M
Eur J Cancer; 2016 Nov; 68():51-59. PubMed ID: 27716478
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Relevance of Palliative Primary Tumor Removal in 37,793 Metastatic Colorectal Cancer Patients: A Population-Based, Propensity Score-Adjusted Trend Analysis.
Tarantino I; Warschkow R; Worni M; Cerny T; Ulrich A; Schmied BM; Güller U
Ann Surg; 2015 Jul; 262(1):112-20. PubMed ID: 25373464
[TBL] [Abstract][Full Text] [Related]
12. Colorectal adenocarcinoma patients with M1a diseases gain more clinical benefits from palliative primary tumor resection than those with M1b diseases: A propensity score matching analysis.
Li CL; Tang DR; Ji J; Zang B; Chen C; Zhao JQ
World J Clin Cases; 2020 Aug; 8(15):3230-3239. PubMed ID: 32874977
[TBL] [Abstract][Full Text] [Related]
13. Impact of neutrophil-lymphocyte and platelet-lymphocyte ratio on antiEGFR and bevacizumab efficacy in metastatic colorectal cancer.
Dogan E; Bozkurt O; Sakalar T; Derin S; Inanc M; Ozkan M
J BUON; 2019; 24(5):1861-1869. PubMed ID: 31786848
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Value of Primary Tumor Sidedness for Unresectable Stage IV Colorectal Cancer: A Retrospective Study.
Shida D; Tanabe T; Boku N; Takashima A; Yoshida T; Tsukamoto S; Kanemitsu Y
Ann Surg Oncol; 2019 May; 26(5):1358-1365. PubMed ID: 30719633
[TBL] [Abstract][Full Text] [Related]
15. Changing management and survival in patients with stage IV colorectal cancer.
Platell C; Ng S; O'bichere A; Tebbutt N
Dis Colon Rectum; 2011 Feb; 54(2):214-9. PubMed ID: 21228671
[TBL] [Abstract][Full Text] [Related]
16. The outcome of primary tumor resection in the unresectable stage IV colorectal cancer patients who received the bevacizumab-containing chemotherapy.
Yeom SS; Lee SY; Kwak HD; Kim CH; Kim YJ; Kim HR
Medicine (Baltimore); 2020 Feb; 99(7):e19258. PubMed ID: 32049866
[TBL] [Abstract][Full Text] [Related]
17. Nonoperative management of primary colorectal cancer in patients with stage IV disease.
Scoggins CR; Meszoely IM; Blanke CD; Beauchamp RD; Leach SD
Ann Surg Oncol; 1999; 6(7):651-7. PubMed ID: 10560850
[TBL] [Abstract][Full Text] [Related]
18. Non-resection versus resection for an asymptomatic primary tumour in patients with unresectable stage IV colorectal cancer.
Cirocchi R; Trastulli S; Abraha I; Vettoretto N; Boselli C; Montedori A; Parisi A; Noya G; Platell C
Cochrane Database Syst Rev; 2012 Aug; (8):CD008997. PubMed ID: 22895981
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of Combining Bevacizumab With First-Line Chemotherapy Regimens for Metastatic Colorectal Cancer in Real-World Practice.
Bang YH; Hong YS; Lee JS; Lee KW; Han HS; Kim SY; Kim JW; Kim HK; Kim JW; Eun CK; Kim TW; Kim JE
Clin Colorectal Cancer; 2021 Jun; 20(2):101-112.e6. PubMed ID: 33223477
[TBL] [Abstract][Full Text] [Related]
20. Surgical Resection of Primary Tumor in Asymptomatic or Minimally Symptomatic Patients With Stage IV Colorectal Cancer: A Canadian Province Experience.
Ahmed S; Fields A; Pahwa P; Chandra-Kanthan S; Zaidi A; Le D; Haider K; Reeder B; Leis A
Clin Colorectal Cancer; 2015 Dec; 14(4):e41-7. PubMed ID: 26140732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
